Standard BioTools Inc. Company Profile
Standard BioTools Inc. as SEC EDGAR records it: incorporation, addresses, industry, fiscal year end, filer category and former names.
- Incorporated: Value 1999-05-19.
- Current registered country: Value Delaware, United States.
- Country of operation (business address): Value United States.
- Business address: Value 50 MILK STREET, 10TH FLOOR, BOSTON, Massachusetts, 02109, United States.
| Measure | Value |
|---|---|
| Incorporated | 1999-05-19 “Description of Business Fluidigm Corporation (the Company) was incorporated in the state of California on May 19, 1999, to commercialize microfluidic technology initially developed at the California Institute of Technology.” 10-K filed 2012-03-26 |
| Current registered country | Delaware, United States SEC EDGAR state of incorporation DE |
| Country of operation (business address) | United States |
| Business address | 50 MILK STREET, 10TH FLOOR, BOSTON, Massachusetts, 02109, United States |
| Mailing address | 50 MILK STREET, 10TH FLOOR, BOSTON, Massachusetts, 02109, United States |
| Industry (SIC) | 2834 Pharmaceutical Preparations |
| Fiscal year end | 12-31 |
| Filer category | Accelerated filer |
| Listed stock (Section 12(b)) | Common Stock, $0.001 par value per share · LAB · The Nasdaq Global Select Market 10-Q filed 2026-08-05 cover |
| Shell company | No 10-Q filed 2026-08-05 cover |
| Smaller reporting company | No 10-Q filed 2026-08-05 cover |
| Emerging growth company | No 10-Q filed 2026-08-05 cover |
| Current in its reporting | Yes 10-Q filed 2026-08-05 cover |
| Well-known seasoned issuer | No 10-K filed 2026-03-16 cover |
| Voluntary filer | No 10-K filed 2026-03-16 cover |
| Former names | FLUIDIGM CORP (2002-01-18 to 2022-04-01) |
| First EDGAR filing | 2002-01-18 (REGDEX/A) |
| SEC CIK | 1162194 |
| EIN | 770513190 |
| Phone | 6502666000 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ROCKET PHARMACEUTICALS, INC. (RCKT) | United States | $0.296B | -21.78 |
| Vanda Pharmaceuticals Inc. (VNDA) | United States | $0.302B | -1.35 |
| Fulcrum Therapeutics, Inc. (FULC) | United States | $0.289B | -3.28 |
| Contineum Therapeutics, Inc. (CTNM) | United States | $0.289B | -4.40 |
| GT Biopharma, Inc. (GTBP) | United States | $0.309B | -4.58 |
| Perspective Therapeutics, Inc. (CATX) | United States | $0.284B | -3.34 |
| Upstream Bio, Inc. (UPB) | United States | $0.284B | -2.42 |
| ABEONA THERAPEUTICS INC. (ABEO) | United States | $0.312B | -5.63 |
| Sagimet Biosciences Inc. (SGMT) | United States | $0.279B | |
| Prelude Therapeutics Inc (PRLD) | United States | $0.318B | -7.01 |